From the MHH

Specialist for bone marrow diseases and cancer: Professor Heidel moves to the MHH

New Director of the Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation succeeds Professor Ganser.

Portrait picture of Florian Heidel

The Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation at Hannover Medical School (MHH) has a new director: Professor Dr Florian Heidel took office today. The specialist for blood and bone marrow diseases and cancer succeeds Professor Dr. Arnold Ganser, who headed the clinic from 1995 to 2022. The specialist in internal medicine, haematology and oncology and palliative medicine was previously Director of the Clinic for Internal Medicine C at Greifswald University Medical Centre. "With Florian Heidel, MHH has been able to gain an outstanding representative of his field, who will strengthen several of MHH's focal areas at once with his clinical and scientific expertise, such as 'Transplantation and Regeneration', 'Infection and Immunity' as well as Oncology and the Comprehensive Cancer Center Lower Saxony (CCC-N)," said MHH President Professor Dr. Michael Manns. He thanked Professor Ganser for his decades of dedication as well as Professor Dr. Matthias Eder, who in the meantime has led the clinic in an excellent acting capacity.

Professor Heidel is looking forward to his new task in Hannover. "MHH offers excellent conditions both in clinical cancer medicine and in research and translation to develop new therapeutic methods for blood cancer such as new targeted drugs or cell therapies," emphasises the 47-year-old. "I am very much looking forward to working with the excellent team at my clinic and the proven experts at MHH."

Florian Heidel had studied and obtained his doctorate in his native city of Erlangen before moving to Mainz for his specialist training. After further stations at Harvard University in Boston and at the university hospitals in Magdeburg, Jena and Greifwald, he now takes over Professor Ganser's clinic. With 146 bone marrow and stem cell transplants (BMT) in 2022, it is one of the major BMT centres in Germany.

Text: Stefan Zorn